Instylla Revenue and Competitors

Location

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 Ben Bell	VP Research & Development and Operations	Reveal Email/Phone
2 Ben Bell	VP Research & Development and Operations	Reveal Email/Phone
3 Amita Shah	VP Quality and Regulatory	Reveal Email/Phone
4 Cynthia George	Sr. Director Program Management & Materials Planning	Reveal Email/Phone
5 Rashmi Prasadnow	Director Marketing	Reveal Email/Phone
6 Janet Desaulniers	Senior Director Business Operations	Reveal Email/Phone
7 Stephanie Cavoores	Senior Clinical Field Manager	Reveal Email/Phone
8 Nicole Rissman	Manager Clinical Affairs	Reveal Email/Phone
9 Marissa Kewley	Clinical Field Support Manager	Reveal Email/Phone
10 Weber Guerrier	Sr. Clinical Field Manager	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 AdviNow Medical	$5M	40	-18%	$10M	N/A
#2 WestPac Surgica...	$24.8M	99	29%	N/A	N/A
#3 Zynex Medical	$84.1M	0	N/A	$1.2M	N/A
#4 Kulzer North Am...	$35.6M	142	30%	N/A	N/A
#5 CAIRE	$57.5M	211	12%	N/A	N/A
#6 Endotronix	$52.7M	168	25%	$129.6M	N/A
#7 Graymont Medica...	$21.1M	64	-7%	N/A	N/A
#8 Avante Health S...	$61.2M	215	8%	N/A	N/A
#9 Stimwave	$60.6M	193	20%	$115.5M	N/A
#10 Neocis	$56.2M	179	-3%	$122.9M	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$12.6M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

... Siranomics, Instylla, Inc. and others are currently working to improve the Intrahepatic Cholangiocarcinoma treatment landscape.

Instylla, Inc., a privately held company developing next-generation liquid embolics for. Figure 1: Before and after embolization images for...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 DesignerAdvanta...	$7.5M	44	-6%	N/A
#2 New York Metro ...	$6M	44	13%	N/A
#3 Solera Global D...	$6.9M	44	-14%	N/A
#4 Hardy and Harpe...	$16.7M	44	5%	N/A
#5 James and Georg...	$13.4M	44	-6%	N/A